Walgreens Boots Alliance (WBA)
(Delayed Data from NSDQ)
$10.68 USD
-0.18 (-1.66%)
Updated Aug 9, 2024 03:59 PM ET
After-Market: $10.71 +0.03 (0.28%) 7:58 PM ET
5-Strong Sell of 5 5
D Value D Growth A Momentum D VGM
Price, Consensus and EPS Surprise
WBA 10.68 -0.18(-1.66%)
Will WBA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for WBA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for WBA
The Zacks Analyst Blog CVS Health, Walgreens and Herbalife
What is the Right Approach for CVS Health (CVS) Post Q2 Results?
WBA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Company News for Aug 6, 2024
Walgreens Boots Alliance, Inc. (WBA) is Attracting Investor Attention: Here is What You Should Know
CVS Health (CVS) Stock Pre-Q2 Earnings: To Buy or Not to Buy?
Other News for WBA
74 S&P 500 stocks that can beat the cash yield - BofA
Walgreens Boots Alliance Announces Pricing of $750,000,000 of Senior Unsecured Notes
This Must Be the Place and Walgreens Expand Access to Naloxone for Music and Art Lovers Across the Country
Walgreens Boots (NASDAQ:WBA) Considers VillageMD Stake Sale
Walgreens Boots Alliance (WBA) Receives a Sell from Barclays